Dr. Oana Danciu
Claim this profileUniversity of Illinois
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
47 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
HER2 negative
2Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Oana Danciu is currently running
RiMO-401 with Radiation
for Advanced Cancer
This is a single arm study of RiMO-401 with radiation in patients with advanced tumors. A single escalation dose of RiMO-401 is intratumorally injected in a 3+3 study design to identify the recommended dose.
Recruiting1 award Phase 1
Neratinib + Endocrine Therapy + Trastuzumab
for Breast Cancer
This trial involves treating breast cancer patients with three drugs: neratinib, an aromatase inhibitor, and trastuzumab. These drugs work together to block cancer growth signals, lower estrogen levels, and help the immune system attack cancer cells. The treatment is aimed at patients with HER2-positive breast cancer who may not respond well to standard treatments. Trastuzumab is a well-established treatment for HER2-positive breast cancer, often used in combination with other therapies.
Recruiting1 award Phase 216 criteria
More about Oana Danciu
Clinical Trial Related9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Oana Danciu has experience with
- Trastuzumab
- Pertuzumab
- Paclitaxel
- Fulvestrant
- Anastrozole
- Letrozole
Breakdown of trials Oana Danciu has run
Breast Cancer
Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Oana Danciu specialize in?
Oana Danciu focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Oana Danciu currently recruiting for clinical trials?
Yes, Oana Danciu is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Oana Danciu has studied deeply?
Yes, Oana Danciu has studied treatments such as Trastuzumab, Pertuzumab, Paclitaxel.
What is the best way to schedule an appointment with Oana Danciu?
Apply for one of the trials that Oana Danciu is conducting.
What is the office address of Oana Danciu?
The office of Oana Danciu is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.